GFP Stable Cell Line-BT474

BT-474 is a human breast cancer cell line established from primary tumors of breast cancer patients. The BT474 cell line has several properties that make it a useful tool in cancer research. It can grow in culture and exhibit many of the same properties as breast cancer cells found in patients. Researchers used the BT-474 cell line to study the molecular mechanisms of breast cancer, including genes and pathways involved in cancer cell growth, invasion and metastasis. The BT-474 cell line is also used to test the efficacy of various cancer treatments, including chemotherapy, radiation therapy and targeted therapy. The GFP stable cell line-BT474 is generated by transforming BT474 cells with a plasmid carrying the GFP gene, resulting in stable integration of the gene into the genome of the BT474 cells. The GFP stable cell line-BT474 enables researchers to monitor the in vitro and in vivo behavior of BT474 subtype breast cancer cells under a variety of experimental conditions. GFP fluorescence provides a real-time, non-invasive indication of cell status, allowing for continuous monitoring and analysis. It can be used to study proliferation, migration, invasion and protein localization as well as other cellular functions in living organisms or populations of living cells in real time. Therefore, the GFP stable cell line-BT474 is a valuable tool in various areas of biomedical research, including cancer biology, drug discovery and development, cell biology, and preclinical research.